Daniel Faga - Mar 22, 2024 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Signature
/s/ Eric Loumeau, Attorney-in-Fact
Stock symbol
ANAB
Transactions as of
Mar 22, 2024
Transactions value $
-$10,894,178
Form type
4
Date filed
3/26/2024, 08:10 PM
Previous filing
Jan 9, 2024
Next filing
Jul 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANAB Common Stock Sale -$3.33M -146K -16.25% $22.78 752K Mar 22, 2024 Direct F1, F2
transaction ANAB Common Stock Sale -$64.3K -3K -0.4% $21.42 749K Mar 25, 2024 Direct F1, F2
transaction ANAB Common Stock Tax liability -$7.5M -347K -46.38% $21.60 402K Mar 26, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person to cover a portion of the tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by "sell to cover transactions" and do not represent discretionary transactions by the Reporting Person.
F2 The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
F3 Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.